Pharmaceutical

City Therapeutics launches with $135m Series A funding

City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.

Oct 10, 2024 - 04:00
City Therapeutics launches with $135m Series A funding
City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.
Read the original article

Tags:

Previous Article

Clinical Dose Companies in Contract Manufacturing for the Pharmaceutical Industry

Next Article

Ipsen’s Elafibranor gains MHRA approval for PBC treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CDC proposes new antibiotics policy aimed at reducing STIs

CDC proposes new antibiotics policy aimed at reducing STIs

Oct 2, 2023

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech and CEPI partner to develop Mpox vaccine

Sep 19, 2023

Novo Nordisk to invest $2.3bn to expand Danish manufacturing facilities

Novo Nordisk to invest $2.3bn to expand Danish manufact...

Jun 13, 2023